Cargando…
Failure of oral 4′, 6-dichloroflavan to protect against rhinovirus infection in man
4′, 6-Dichloroflavan, a potent inhibitor of rhinovirus replicationin vitro, was tested in a double-blind placebo controlled volunteer trial for its protective effect against experimental rhinovirus infection. Dichloroflavan was given orally (1 mg/kg, 3 times per day) for 3 doses before, and 13 doses...
Autores principales: | Phillpotts, R. J., Wallace, J., Tyrrell, D. A. J., Freestone, D. S., Shepherd, W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087276/ https://www.ncbi.nlm.nih.gov/pubmed/6338868 http://dx.doi.org/10.1007/BF01314131 |
Ejemplares similares
-
4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound
por: Bauer, D. J., et al.
Publicado: (1981) -
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-α(2)()
por: Phillpotts, R.J., et al.
Publicado: (1983) -
The effect of prior inoculation with an enterovirus (LEV 4) on rhinovirus infection of volunteers
por: Matthews, T. H. J., et al.
Publicado: (1974) -
Studies of rhinoviruses and coronaviruses at the Common Cold Unit, Salisbury, Wiltshire.
por: Tyrrell, D. A.
Publicado: (1979) -
Use of synthetic oligonucleotide probes to detect rhinovirus RNA
por: Bruce, Christine B., et al.
Publicado: (1989)